SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Considers Endorsement of Boehringer Ingelheim Corporation Drug that Come Call Viagra for Women

May 24, 2010 | 
1 min read
Washington Post -- A panel of federal advisers will soon wrestle with a question that has bedeviled poets, philosophers and generations of frustrated men: What do women want?
Regulatory
MORE ON THIS TOPIC
Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts
Policy
FDA taps prior knowledge to expedite cell and gene therapy development
June 3, 2026
 · 
12 min read
 · 
BioSpace Editorial Staff
Pointing up with fingers number three. Close up, isolated on white background.
Cancer
Replimune gives cancer immunotherapy a third try after FDA leadership shakeup
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman carrying a stopwatch on a progress bar illustrating last minute deadline to complete a business project
Regulatory
FDA delays verdict on Beren’s rare disease drug by three months
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of hands with thumbs up in a row, radiating positivity and consensus in bright tones on a clean background
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
May 28, 2026
 · 
1 min read
 · 
Tristan Manalac